Drug Type Mesenchymal stem cell therapy |
Synonyms allogenic haMPC therapy Cellular Biomedicine Group, 异体人源脂肪间充质祖细胞(西比曼), AlloJoin |
Target- |
Mechanism Cell replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 3 | CN | 12 Jul 2023 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | CN | 02 Jun 2022 |